Five Prime Therapeutics, Inc. Earnings Per Share (Diluted)
Five Prime Therapeutics, Inc. reported Earnings Per Share (Diluted) of -$5.38 per share for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2018-02-27
- Five Prime Therapeutics, Inc. earnings per share, diluted for the quarter ending 2015-12-31 was $10.63.
- Five Prime Therapeutics, Inc. earnings per share, diluted for the quarter ending 2015-09-30 was -$0.93.
- Five Prime Therapeutics, Inc. earnings per share, diluted for the quarter ending 2015-06-30 was -$0.45.
- Five Prime Therapeutics, Inc. earnings per share, diluted for the quarter ending 2015-03-31 was -$0.44.
- Five Prime Therapeutics, Inc. earnings per share, diluted for fiscal 2017 was -$5.38.
- Five Prime Therapeutics, Inc. earnings per share, diluted for fiscal 2016 was -$2.44, a 126.44% decline from fiscal 2015.
- Five Prime Therapeutics, Inc. earnings per share, diluted for fiscal 2015 was $9.23.
- Five Prime Therapeutics, Inc. earnings per share, diluted for fiscal 2014 was -$1.79.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 12 month |
|---|---|---|
| 2017-12-31 | -$5.38 10-K · filed 2018-02-27 | |
| 2016-12-31 | -$2.44 10-K · filed 2018-02-27 | |
| 2015-12-31 | $10.63 10-K · filed 2017-02-24 | $9.23 10-K · filed 2018-02-27 |
| 2015-09-30 | -$0.93 10-K · filed 2017-02-24 | |
| 2015-06-30 | -$0.45 10-K · filed 2017-02-24 | |
| 2015-03-31 | -$0.44 10-K · filed 2017-02-24 | |
| 2014-12-31 | -$1.79 10-K · filed 2017-02-24 | |
| 2013-12-31 | -$5.23 10-K · filed 2016-03-11 | |
| 2012-12-31 | -$23.05 10-K · filed 2015-03-18 | |
| 2011-12-31 | $0.72 10-K · filed 2014-03-26 |